CN Stock MarketDetailed Quotes

600285 Henan Lingrui Pharmaceutical

Watchlist

22.34
+1.13+5.33%

Market Closed Dec 19 15:00 CST

12.67BMarket Cap18.74P/E (TTM)

Henan Lingrui Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Henan Lingrui Pharmaceutical Q3 2024 Earnings Date

Currency：CNYOct 30, 2024

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	--	853.11M	--
		+5.83%
EPS	--	0.29	--
		--

Analyst Rating

Strong Buy

Dec 19, 2024

Henan Lingrui Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/FY	-- / 4.194B	--
--	2024/FY	-- / 3.723B	--
--	2023/FY	3.311B / 3.455B	--
--	2022/FY	3.002B / 3.146B	--
--	2021/FY	2.694B / 2.780B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/FY-- / 4.194B--

--2024/FY-- / 3.723B--

--2023/FY3.311B / 3.455B--

--2022/FY3.002B / 3.146B--

--2021/FY2.694B / 2.780B--

Unlock Free Earnings Estimates

Open Account

Henan Lingrui Pharmaceutical Earnings Reports

Ling Rui Pharmaceutical Report for the Third Quarter of 2024

Oct 29 12:00 ET

Henan Lingrui Pharmaceutical Semi-Annual Report 2024

Aug 12 12:00 ET

Summary of Henan Lingrui Pharmaceutical's Half-Year Report in 2024.

Aug 12 12:00 ET

Ling Rui Pharmaceutical's 2024 First Quarter Report

Apr 25 12:00 ET

Symbol Price % Chg

Dark Horse Technology Group

Shanghai Kaytune Industrial

301001

34.19 +20.01%

See the daily top gainer.

Analysis

Analyst Rating

Updated: Dec 19, 2024

Strong Buy

Strong Buy
81.25%
Buy
18.75%
Hold
0.00%
Underperform
0.00%
Sell
0.00%

Price Target

No Data

Investment Theme

Pension Holdings

Intraday+0.44%